AHCL.NS

ANLON HEALTHCARE LIMITED

NSEHealthcare

₹15.89

▼ -0.06%-₹0.01 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹15.90

Day range

₹0 – ₹0

52W range

₹12.91 – ₹161

Volume

1.3Cr

Avg vol (20D)

96.5L

Mkt cap

₹843.51Cr

P/E TTM

26.0×

Trade ANLON HEALTHCARE LIMITED with Artha

Company Metrics

Revenue (ttm)₹171.97 Cr

Net Income (ttm)₹0.00

Shares Out53.15 Cr

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.00

About AHCL.NS

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

Employees0

Stock ExchangeNSE

Ticker SymbolAHCL.NS

Websitehttps://www.anlon.in

AHCL.NS · NSE

Financial Performance

In 2026, ANLON HEALTHCARE LIMITED's revenue was ₹171.97 Cr, an increase of +4.00% compared to the previous year. Earnings were ₹0.00, an decrease of +54.80%.

Revenue (2026)

₹171.97 Cr

↗+4.00% YoY

Earnings (2026)

₹0.00

↘-54.80% YoY

Year-over-Year Growth

Revenue

+4.00%

Earnings

-54.80%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account